Skip to content

Clinical trials

Lung Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Brazil Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20063
20072
20082
20093
20101
20111
20121
20131
20142
20156
20161
20171
20182
20193
20203
20214
20223
20235
20249
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting17
Active, not recruiting11
Unknown status6
Terminated5
Not yet recruiting3
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Bristol-Myers Squibb5
Pfizer5
Eli Lilly and Company4
Latin American Cooperative Oncology Group4
Amgen3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
NCIC Clinical Trials Group3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms76
Carcinoma, Non-Small-Cell Lung44
Neoplasm Metastasis7
Neoplasms7
Carcinoma5
Lung Diseases4
Small Cell Lung Carcinoma4
Adenocarcinoma of Lung3
Breast Neoplasms2
Carcinoma, Bronchogenic2

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.